StemWave is a medical technology company focused on advancing non-invasive care through real-world results. We partner with clinics, health systems, and sports organizations to deliver technology that improves outcomes, integrates seamlessly into existing care models, and holds up in daily practice. Our approach prioritizes reliability, provider support, and long-term value over hype or short-term trends. At our core, we believe better care starts with offering the right solutions. Innovation should expand what providers can offer patients, restore confidence in non-invasive solutions, and earn trust through consistent, meaningful outcomes built to last.
| Website | https://linktr.ee/stemwave_linkedin |
| Revenue | $11.3 million |
| Employees | 82 (57 on RocketReach) |
| Founded | 2022 |
| Address | 280 Summer St, Boston, Massachusetts 02210, US |
| Industry | Medical Devices |
| Keywords | Patient Care, Regenerative Medicine, Regenerative Medicine Technology, Cellular Therapy, Therapeutic Technology, Healthcare Technology, Treatment Solutions, Cell Therapy, Effective Treatments, Medical Technology, Medical Devices, Clinical Solutions, Healthcare Innovation, Biotechnology, Medical Innovation, Health Tech, Medical Research, Clinical Research, Digital Health |
| Competitors | Medtronic, Stryker, Zimmer Biomet, B. Braun Group, Orthofix, AlloSource®, Spine Wave, Inc., Johnson & Johnson MedTech Germany, Impulse Monitoring, Apex Biotechnology Corp +34 more (view full list) |
Looking for a particular StemWave employee's phone or email?
The StemWave annual revenue was $11.3 million in 2026.
Tom Kostopoulos is the CEO, Founder of StemWave.
57 people are employed at StemWave.
StemWave is based in Boston, Massachusetts.